Evidence map›Paper›PMID 32168809›Full record

ReviewFoods (Basel, Switzerland)2020

Nanostructured Lipid-Based Delivery Systems as a Strategy to Increase Functionality of Bioactive Compounds.

Ariadna Gasa-Falcon, Isabel Odriozola-Serrano, Gemma Oms-Oliu, Olga Martín-Belloso

Abstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Storage stability andFrontiers in nutrition · 2022
    Article
  12. Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats.European journal of drug metabolism and pharmacokinetics · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariadna Gasa-FalconDepartment of Food Technology, University of Lleida-Agrotecnio Center, Av. Rovira Roure 191, 25198 Lleida, Spain.
Isabel Odriozola-SerranoDepartment of Food Technology, University of Lleida-Agrotecnio Center, Av. Rovira Roure 191, 25198 Lleida, Spain.
Gemma Oms-OliuDepartment of Food Technology, University of Lleida-Agrotecnio Center, Av. Rovira Roure 191, 25198 Lleida, Spain.
Olga Martín-BellosoDepartment of Food Technology, University of Lleida-Agrotecnio Center, Av. Rovira Roure 191, 25198 Lleida, Spain.

Funding

Agencia Estatal de Investigación RTI2018-094268-B-C21Fondo Europeo de Desarrollo Regional AGL2015-65975-RFondo Europeo de Desarrollo Regional RTI2018-094268-B-C21Ministerio de Ciencia, Innovación y Universidades RTI2018-094268-B-C21Ministerio de Economía y Empresa España AGL2015-65975-R
6 · The paper itself

Abstract

Acquisition of a healthy lifestyle through diet has driven the food manufacturing industry to produce new food products with high nutritional quality. In this sense, consumption of bioactive compounds has been associated with a decreased risk of suffering chronic diseases. Nonetheless, due to their low solubility in aqueous matrices, high instability in food products during processing and preparation as well as poor bioavailability, the use of such compounds is sometimes limited. Recent advancements in encapsulation and protection of bioactive compounds has opened new possibilities for the development of novel food products. In this direction, the present review is attempting to describe encapsulation achievements, with special attention to nanostructured lipid-based delivery systems, i.e., nanoemulsions, multi-layer emulsions and liposomes. Functionality of bioactive compounds is directly associated with their bioavailability, which in turn is governed by several complex processes, including the passage through the gastrointestinal tract and transport to epithelial cells. Therefore, an overview of recent research on the properties of these nanostructured lipid-based delivery systems with a strong impact on the functionality of bioactive compounds will be also provided. Nanostructured lipid-based delivery systems might be used as a potential option to enhance the solubility, stability, absorption and, ultimately, functionality of bioactive compounds. Several studies have been performed in this line, modifying the composition of the nanostructures, such as the lipid-type or surfactants. Overall, influencing factors and strategies to improve the efficacy of encapsulated bioactive compounds within nanostructures have been successfully identified. This knowledge can be used to design effective targeted nanostructured lipid-based delivery systems for bioactive compounds. However, there is still a lack of information on food interactions, toxicity and long-term consumption of such nanostructures.

Indexed as

absorptionbioaccessibilitybioactive compoundsfunctionalitylipid digestibilityliposomesmulti-layer emulsionsnanoemulsionsstability

Identifiers

PMID32168809
PMCPMC7143550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.